Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,982 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mapping the emergence of molecular vibrations mediating bond formation.
Kim JG, Nozawa S, Kim H, Choi EH, Sato T, Kim TW, Kim KH, Ki H, Kim J, Choi M, Lee Y, Heo J, Oang KY, Ichiyanagi K, Fukaya R, Lee JH, Park J, Eom I, Chun SH, Kim S, Kim M, Katayama T, Togashi T, Owada S, Yabashi M, Lee SJ, Lee S, Ahn CW, Ahn DS, Moon J, Choi S, Kim J, Joo T, Kim J, Adachi SI, Ihee H. Kim JG, et al. Among authors: choi m, choi eh, choi s. Nature. 2020 Jun;582(7813):520-524. doi: 10.1038/s41586-020-2417-3. Epub 2020 Jun 24. Nature. 2020. PMID: 32581378
Author Correction: Mapping the emergence of molecular vibrations mediating bond formation.
Kim JG, Nozawa S, Kim H, Choi EH, Sato T, Kim TW, Kim KH, Ki H, Kim J, Choi M, Lee Y, Heo J, Oang KY, Ichiyanagi K, Fukaya R, Lee JH, Park J, Eom I, Chun SH, Kim S, Kim M, Katayama T, Togashi T, Owada S, Yabashi M, Lee SJ, Lee S, Ahn CW, Ahn DS, Moon J, Choi S, Kim J, Joo T, Kim J, Adachi SI, Ihee H. Kim JG, et al. Among authors: choi m, choi eh, choi s. Nature. 2021 Nov;599(7883):E1. doi: 10.1038/s41586-021-04036-7. Nature. 2021. PMID: 34650239 No abstract available.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 8:S0140-6736(24)02551-0. doi: 10.1016/S0140-6736(24)02551-0. Online ahead of print. Lancet. 2025. PMID: 39798579
8,982 results